Nasdaq · CIK 0001092699
SPSC SPS COMMERCE INC
Insider trading from SEC Form 4. Last filing Mar 17, 2026. Close $84.59 on Oct 9, 2026, +69% from the 52-week low and -25% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at SPS COMMERCE INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Marty M Reaume director sell | $63k 1,000 shares | -10% | +15% from low-59% from high | |
| 47Moderate | Chadwick Collins Chief Executive Officer sell | $785k 13,384 shares | -16% | 0% from low-62% from high | |
| 32Weak | Kimberly K. Nelson EVP & CFO sell | $370k 6,300 shares | -4% | 0% from low-62% from high | |
| 21Weak | Jamie Thingelstad EVP, Chief Technology Officer sell | $133k 2,418 shares | -4% | 0% from low-65% from high | |
| 4Weak | Marty M Reaume director sell | $80k 1,000 shares | -10% | 0% from low-57% from high | |
| 0Weak | Marty M Reaume director sell | $160k 1,732 shares | -16% | +19% from low-53% from high | |
| 33Weak | Chadwick Collins Chief Executive Officer sell | $662k 4,512 shares | -0% | - | |
| 21Weak | Dan Juckniess EVP, Chief Sales Officer sell | $490k 3,326 shares | -0% | - | |
| 30Weak | Dan Juckniess EVP, Chief Sales Officer sell | $2.3M 12,214 shares | -38% | - | |
| 20Weak | Dan Juckniess EVP, Chief Sales Officer sell | $674k 3,658 shares | -15% | - | |
| 30Weak | Dan Juckniess EVP, Chief Sales Officer sell | $1.2M 5,831 shares | -20% | - | |
| 7Weak | Dan Juckniess EVP, Chief Sales Officer sell | $60k 300 shares | -1% | - | |
| 35Weak | Chadwick Collins Chief Executive Officer sell | $1.2M 6,839 shares | -11% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 26, 2025 | KIMBERLY NELSON Officer | 5,490 0.01% of outstanding | $760k | Feb 26, 2025 | $4.2M |
| Feb 20, 2025 | CHADWICK COLLINS Director, Officer | 1,672 0.00% of outstanding | $245k | Feb 20, 2025 | $421k |
| Feb 20, 2025 | DANIEL JUCKNIESS Officer | 735 0.00% of outstanding | $108k | Feb 20, 2025 | $4.5M |
| Feb 20, 2025 | KIMBERLY NELSON Officer | 1,456 0.00% of outstanding | $214k | Feb 20, 2025 | $4.0M |
| Feb 20, 2025 | JAMIE THINGELSTAD Officer | 740 0.00% of outstanding | $109k | Feb 20, 2025 | $1.2M |
| Feb 19, 2025 | CHADWICK COLLINS Director, Officer | 2,840 0.01% of outstanding | $415k | Feb 19, 2025 | none |
| Feb 19, 2025 | DANIEL JUCKNIESS Officer | 2,591 0.01% of outstanding | $379k | Feb 19, 2025 | $4.2M |
| Feb 19, 2025 | KIMBERLY NELSON Officer | 4,034 0.01% of outstanding | $590k | Feb 19, 2025 | $3.4M |
| Feb 19, 2025 | JAMIE THINGELSTAD Officer | 2,216 0.01% of outstanding | $324k | Feb 19, 2025 | $887k |
| Feb 5, 2025 | KIMBERLY NELSON Officer | 9,290 0.02% of outstanding | $1.7M | Feb 5, 2025 | $1.7M |
| Jan 31, 2025 | DANIEL JUCKNIESS Officer | 2,395 0.01% of outstanding | $439k | Jan 31, 2025 | $3.7M |
| Jan 31, 2025 | JAMIE THINGELSTAD Officer | 68 0.00% of outstanding | $12k | Jan 31, 2025 | $875k |
| Jan 30, 2025 | JAMES FROME Officer | 23,594 0.06% of outstanding | $4.4M | Jan 30, 2025 | $8.1M |
| Jan 30, 2025 | DANIEL JUCKNIESS Officer | 9,273 0.02% of outstanding | $1.7M | Jan 30, 2025 | $1.9M |
| Jan 30, 2025 | KIMBERLY NELSON Officer | 9,290 0.02% of outstanding | $1.7M | Jan 30, 2025 | none |
| Jan 30, 2025 | JAMIE THINGELSTAD Officer | 4,730 0.01% of outstanding | $888k | Jan 30, 2025 | none |
| Jan 3, 2025 | FROME LIVING TRUST Officer | 43,466 0.12% of outstanding | $7.9M | Jan 3, 2025 | none |
| Dec 11, 2024 | DANIEL JUCKNIESS Officer | 10,335 0.03% of outstanding | $2.0M | Dec 11, 2024 | none |
| Nov 5, 2024 | CHADWICK COLLINS Director, Officer | 6,839 0.02% of outstanding | $1.1M | Nov 5, 2024 | none |
Transactions
The last 82 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Tami Reller director | MOption exercise Common Stock | +5,732 | $51.80 | $297k | 51,172 | Mar 17, 2026 |
| Mar 13, 2026 | Tami Reller director | MOption exercise Stock Option (right to buy)derivative | -5,732 | $0.00 | $0 | 0 | Mar 17, 2026 |
| Mar 9, 2026 | Marty M Reaume director | MOption exercise Common Stock10b5-1 | +1,000 | $51.80 | $52k | 10,158 | Mar 11, 2026 |
| Mar 9, 2026 | Marty M Reaume director | SOpen-market sale Common Stock10b5-1 | -1,000 | $62.73 | $63k | 9,158 | Mar 11, 2026 |
| Mar 9, 2026 | Marty M Reaume director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 2,000 | Mar 11, 2026 |
| Feb 20, 2026 | Jamie Thingelstad EVP, Chief Technology Officer | AGrant or award Common Stock10b5-1 | +23,295 | $0.00 | $0 | 58,762 | Feb 24, 2026 |
| Feb 20, 2026 | Fumbi F. Chima director | AGrant or award Common Stock | +3,451 | $0.00 | $0 | 3,451 | Feb 24, 2026 |
| Feb 20, 2026 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -7,776 | $58.09 | $452k | 77,849 | Feb 24, 2026 |
| Feb 20, 2026 | Eduardo Rosini EVP, Chief Commercial Officer | AGrant or award Common Stock | +29,335 | $0.00 | $0 | 109,860 | Feb 24, 2026 |
| Feb 20, 2026 | Michael J McConnell director | AGrant or award Common Stock | +3,451 | $0.00 | $0 | 3,451 | Feb 24, 2026 |
| Feb 20, 2026 | Kimberly K. Nelson EVP & CFO | SOpen-market sale Common Stock10b5-1 | -3,700 | $58.09 | $215k | 148,052 | Feb 24, 2026 |
| Feb 24, 2026 | Jamie Thingelstad EVP, Chief Technology Officer | SOpen-market sale Common Stock10b5-1 | -1,900 | $54.80 | $104k | 56,862 | Feb 24, 2026 |
| Feb 20, 2026 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,806 | $59.18 | $166k | 75,043 | Feb 24, 2026 |
| Feb 20, 2026 | Kimberly K. Nelson EVP & CFO | SOpen-market sale Common Stock10b5-1 | -1,200 | $59.19 | $71k | 146,852 | Feb 24, 2026 |
| Feb 20, 2026 | Kimberly K. Nelson EVP & CFO | SOpen-market sale Common Stock10b5-1 | -1,400 | $59.70 | $84k | 145,452 | Feb 24, 2026 |
| Feb 20, 2026 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,802 | $59.72 | $167k | 72,241 | Feb 24, 2026 |
| Feb 24, 2026 | Jamie Thingelstad EVP, Chief Technology Officer | SOpen-market sale Common Stock10b5-1 | -518 | $55.47 | $29k | 56,344 | Feb 24, 2026 |
| Feb 20, 2026 | Chadwick Collins Chief Executive Officer | AGrant or award Common Stock10b5-1 | +101,932 | $0.00 | $0 | 174,173 | Feb 24, 2026 |
| Feb 20, 2026 | Kimberly K. Nelson EVP & CFO | AGrant or award Common Stock10b5-1 | +39,689 | $0.00 | $0 | 185,141 | Feb 24, 2026 |
| Feb 9, 2026 | Marty M Reaume director | MOption exercise Common Stock10b5-1 | +1,000 | $51.80 | $52k | 10,158 | Feb 11, 2026 |
| Feb 9, 2026 | Marty M Reaume director | SOpen-market sale Common Stock10b5-1 | -1,000 | $79.92 | $80k | 9,158 | Feb 11, 2026 |
| Feb 9, 2026 | Marty M Reaume director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 3,000 | Feb 11, 2026 |
| Jan 7, 2026 | Marty M Reaume director | MOption exercise Common Stock10b5-1 | +1,732 | $51.80 | $90k | 10,890 | Jan 9, 2026 |
| Jan 7, 2026 | Marty M Reaume director | SOpen-market sale Common Stock10b5-1 | -400 | $91.40 | $37k | 10,490 | Jan 9, 2026 |
| Jan 7, 2026 | Marty M Reaume director | SOpen-market sale Common Stock10b5-1 | -1,332 | $92.52 | $123k | 9,158 | Jan 9, 2026 |
| Jan 7, 2026 | Marty M Reaume director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,732 | $0.00 | $0 | 4,000 | Jan 9, 2026 |
| Dec 1, 2025 | Eduardo Rosini EVP, Chief Commercial Officer | AGrant or award Common Stock | +80,525 | $0.00 | $0 | 80,525 | Dec 3, 2025 |
| Nov 18, 2025 | Philip Soran director | MOption exercise Common Stock | +5,732 | $51.80 | $297k | 25,894 | Nov 20, 2025 |
| Nov 18, 2025 | Philip Soran director | FTax withholding Common Stock | -3,717 | $79.89 | $297k | 22,177 | Nov 20, 2025 |
| Nov 18, 2025 | Philip Soran director | MOption exercise Stock Option (right to buy)derivative | -5,732 | $0.00 | $0 | 0 | Nov 20, 2025 |
| Nov 6, 2025 | Mark Partin director | AGrant or award Common Stock | +2,485 | $0.00 | $0 | 2,485 | Nov 10, 2025 |
| Nov 4, 2025 | Jamie Thingelstad EVP, Chief Technology Officer | MOption exercise Common Stock | +8,118 | $54.54 | $443k | 42,088 | Nov 6, 2025 |
| Nov 4, 2025 | Jamie Thingelstad EVP, Chief Technology Officer | FTax withholding Common Stock | -6,621 | $82.53 | $546k | 35,467 | Nov 6, 2025 |
| Nov 4, 2025 | Jamie Thingelstad EVP, Chief Technology Officer | MOption exercise Stock Option (right to buy)derivative | -8,118 | $0.00 | $0 | 0 | Nov 6, 2025 |
| Feb 18, 2025 | Dan Juckniess EVP, Chief Sales Officer | AGrant or award Common Stock | +11,627 | $0.00 | $0 | 31,802 | Jun 27, 2025 |
| Feb 18, 2025 | Jamie Thingelstad EVP, Chief Technology Officer | AGrant or award Common Stock | +9,233 | $0.00 | $0 | 36,926 | Jun 27, 2025 |
| May 13, 2025 | Anne Sempowski Ward director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 4,134 | May 15, 2025 |
| May 13, 2025 | Sven Wehrwein director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 17,522 | May 15, 2025 |
| May 13, 2025 | Philip Soran director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 20,162 | May 15, 2025 |
| May 13, 2025 | Tami Reller director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 45,440 | May 15, 2025 |
| May 13, 2025 | Marty M Reaume director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 9,158 | May 15, 2025 |
| May 13, 2025 | Razat Gaurav director | AGrant or award Common Stock | +1,310 | $0.00 | $0 | 1,310 | May 15, 2025 |
| May 1, 2025 | Razat Gaurav director | AGrant or award Stock Option (right to buy)derivative | +3,648 | $0.00 | $0 | 3,648 | May 5, 2025 |
| Feb 18, 2025 | Dan Juckniess EVP, Chief Sales Officer | AGrant or award Common Stock | +1,350,000 | $0.00 | $0 | 1,370,175 | Feb 20, 2025 |
| Feb 18, 2025 | Chadwick Collins Chief Executive Officer | AGrant or award Common Stock | +5,218,500 | $0.00 | $0 | 5,272,946 | Feb 20, 2025 |
| Feb 19, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,028 | $146.74 | $151k | 5,271,918 | Feb 20, 2025 |
| Feb 19, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -991 | $146.75 | $145k | 1,369,184 | Feb 20, 2025 |
| Feb 19, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -400 | $148.26 | $59k | 1,368,784 | Feb 20, 2025 |
| Feb 19, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -312 | $147.97 | $46k | 5,271,606 | Feb 20, 2025 |
| Feb 19, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,200 | $148.98 | $179k | 1,367,584 | Feb 20, 2025 |
| Feb 19, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,300 | $148.96 | $194k | 5,270,306 | Feb 20, 2025 |
| Feb 19, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -200 | $150.01 | $30k | 5,270,106 | Feb 20, 2025 |
| Feb 20, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -447 | $143.94 | $64k | 1,367,137 | Feb 20, 2025 |
| Feb 20, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,062 | $143.92 | $153k | 5,269,044 | Feb 20, 2025 |
| Feb 20, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -216 | $144.67 | $31k | 1,366,921 | Feb 20, 2025 |
| Feb 20, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -510 | $144.56 | $74k | 5,268,534 | Feb 20, 2025 |
| Feb 20, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -72 | $145.60 | $10k | 1,366,849 | Feb 20, 2025 |
| Feb 20, 2025 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -100 | $145.58 | $15k | 5,268,434 | Feb 20, 2025 |
| Jan 29, 2025 | Dan Juckniess EVP, Chief Sales Officer | AGrant or award Common Stock10b5-1 | +12,214 | $0.00 | $0 | 32,389 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -4,446 | $183.41 | $815k | 27,943 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,400 | $184.25 | $258k | 26,543 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,873 | $185.35 | $347k | 24,670 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,300 | $186.43 | $242k | 23,370 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -501 | $187.46 | $94k | 22,869 | Feb 3, 2025 |
| Jan 30, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -299 | $188.29 | $56k | 22,570 | Feb 3, 2025 |
| Jan 31, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,024 | $184.32 | $189k | 21,546 | Feb 3, 2025 |
| Jan 31, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -1,171 | $185.04 | $217k | 20,375 | Feb 3, 2025 |
| Jan 31, 2025 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -200 | $186.34 | $37k | 20,175 | Feb 3, 2025 |
| Dec 31, 2024 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -200 | $183.11 | $37k | 23,633 | Jan 3, 2025 |
| Dec 31, 2024 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -2,758 | $184.14 | $508k | 20,875 | Jan 3, 2025 |
| Dec 31, 2024 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock10b5-1 | -700 | $185.17 | $130k | 20,175 | Jan 3, 2025 |
| Dec 18, 2024 | Dan Juckniess EVP, Chief Sales Officer | MOption exercise Common Stock | +5,831 | $56.25 | $328k | 29,664 | Dec 20, 2024 |
| Dec 18, 2024 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock | -5,831 | $200.31 | $1.2M | 23,833 | Dec 20, 2024 |
| Dec 18, 2024 | Dan Juckniess EVP, Chief Sales Officer | MOption exercise Stock Option (right to buy)derivative | -5,831 | $0.00 | $0 | 4,204 | Dec 20, 2024 |
| Dec 11, 2024 | Dan Juckniess EVP, Chief Sales Officer | MOption exercise Common Stock | +300 | $56.25 | $17k | 24,005 | Dec 13, 2024 |
| Dec 11, 2024 | Dan Juckniess EVP, Chief Sales Officer | SOpen-market sale Common Stock | -300 | $200.13 | $60k | 23,705 | Dec 13, 2024 |
| Dec 11, 2024 | Dan Juckniess EVP, Chief Sales Officer | MOption exercise Stock Option (right to buy)derivative | -300 | $0.00 | $0 | 10,035 | Dec 13, 2024 |
| Nov 5, 2024 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -900 | $166.51 | $150k | 60,385 | Nov 7, 2024 |
| Nov 5, 2024 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -703 | $167.57 | $118k | 59,682 | Nov 7, 2024 |
| Nov 5, 2024 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,000 | $169.25 | $169k | 58,682 | Nov 7, 2024 |
| Nov 5, 2024 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -1,841 | $170.19 | $313k | 56,841 | Nov 7, 2024 |
| Nov 5, 2024 | Chadwick Collins Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,395 | $171.31 | $410k | 54,446 | Nov 7, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Fumbi F. Chimadirector
- Chadwick CollinsChief Executive Officer
- Razat Gauravdirector
- Dan JuckniessEVP, Chief Sales Officer
- Michael J McConnelldirector
- Kimberly K. NelsonEVP & CFO
- Mark Partincfo, officer, director
- Marty M Reaumedirector
- Tami Rellerdirector
- Eduardo RosiniEVP, Chief Commercial Officer
- Philip Sorandirector
- Jamie ThingelstadEVP, Chief Technology Officer
- Sven Wehrweindirector
- Anne Sempowski Warddirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.